Lotus Pharmaceutical Co., Ltd. (TPE:1795)
290.50
+4.50 (1.57%)
Oct 28, 2025, 2:38 PM CST
Lotus Pharmaceutical Revenue
Lotus Pharmaceutical had revenue of 4.75B TWD in the quarter ending June 30, 2025, with 0.09% growth. This brings the company's revenue in the last twelve months to 19.12B, up 12.91% year-over-year. In the year 2024, Lotus Pharmaceutical had annual revenue of 18.58B with 9.59% growth.
Revenue (ttm)
19.12B
Revenue Growth
+12.91%
P/S Ratio
4.00
Revenue / Employee
17.40M
Employees
1,099
Market Cap
76.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.58B | 1.63B | 9.59% |
| Dec 31, 2023 | 16.96B | 2.33B | 15.89% |
| Dec 31, 2022 | 14.63B | 1.98B | 15.68% |
| Dec 31, 2021 | 12.65B | 1.92B | 17.90% |
| Dec 31, 2020 | 10.73B | 1.12B | 11.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.67B |
| Sunmax Biotechnology | 1.95B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |